EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Exploratory Study of the Impact of a CCL21‐Derived C‐Terminal Peptide on Dendritic Cell Lymph Node Homing

Marina Barrio-Calvo iD, Astrid Sissel Muldorff Frellsen, Emma Probst Brandum, Mette Marie Rosenkilde iD, Eoghan Connors, Per Basse, Pawel Kalinski, Gertrud Malene Hjortø iD

Journal of Immunology Research · 2026-01 · 2026 (1)

DOI: 10.1155/jimr/8833079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, online erschienen am 05.01.2026. Verfasst von Marina Barrio-Calvo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, ku.dk. Hauptthemen laut MEDLINE: Dendritic Cells, Chemokine CCL21, Lymph Nodes, Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovationsfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effective trafficking of dendritic cells (DCs) to the lymph nodes (LNs), orchestrated by CC‐chemokine receptor 7 (CCR7) and its ligand CCL21, is essential for the success of DC–based immunotherapies. This study explores the potential of C21TP, a naturally occurring basic peptide derived from the C‐terminal of CCL21, to enhance DC homing to the draining LNs in a murine model of DC migration. C21TP, containing three clusters of basic residues, significantly boosts CCL21‐mediated signaling and chemotaxis of DCs in vitro. In vivo, DCs formulated with C21TP prior to injection migrated more efficiently to the draining LNs than DCs alone or DCs formulated with a mutated version of C21TP, harboring substitutions in key basic residues. Further studies are needed to evaluate the impact of C21TP on T‐cell priming efficacy in the context of DC–based immunotherapies. Nonetheless, C21TP’s ability to enhance lymph node homing of adoptively transferred cells without additional cellular modifications could offer a practical and scalable approach for advancing future DC–based vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsChemokine CCL21Lymph NodesPeptidesAnimalsMiceCell MovementReceptors, CCR7Mice, Inbred C57BLSignal Transduction

Stichwörter der Autor:innen

CCR7dendritic cellsdendritic-cell migrationlymph node homing

Substanzen

Chemokine CCL21Receptors, CCR7Ccr7 protein, mousePeptides

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, ku.dk.
  • Evaxion A/S, Hørsholm, Denmark.
  • Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA, roswellpark.org.

ORCID-Profile: Marina Barrio-Calvo, Mette Marie Rosenkilde, Gertrud Malene Hjortø

Förderung

  • Innovationsfonden

Zitieren

APA

Barrio-Calvo, M., Frellsen, A. S. M., Brandum, E. P., Rosenkilde, M. M., Connors, E., Basse, P., Kalinski, P., & Hjortø, G. M. (2026). An Exploratory Study of the Impact of a CCL21‐Derived C‐Terminal Peptide on Dendritic Cell Lymph Node Homing. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/8833079

Vancouver

Barrio-Calvo M, Frellsen ASM, Brandum EP, Rosenkilde MM, Connors E, Basse P, et al. An Exploratory Study of the Impact of a CCL21‐Derived C‐Terminal Peptide on Dendritic Cell Lymph Node Homing. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/8833079

BibTeX
@article{BarrioCalvo2026,
  author = {Barrio-Calvo, Marina and Frellsen, Astrid Sissel Muldorff and Brandum, Emma Probst and Rosenkilde, Mette Marie and Connors, Eoghan and Basse, Per and Kalinski, Pawel and Hjortø, Gertrud Malene},
  title = {An Exploratory Study of the Impact of a CCL21‐Derived C‐Terminal Peptide on Dendritic Cell Lymph Node Homing},
  journal = {Journal of Immunology Research},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jimr/8833079}
}
Kostenlos starten →